Chemistry of inorganic compounds – Phosphorus or compound thereof – Oxygen containing
Reexamination Certificate
2007-07-24
2007-07-24
Schnizer, Richard (Department: 1635)
Chemistry of inorganic compounds
Phosphorus or compound thereof
Oxygen containing
C427S002270, C424S423000, C514S04400A
Reexamination Certificate
active
10393507
ABSTRACT:
Provided is a method for production of nanocrystalline hydroxyapatite particles, and nanocrystalline hydroxyapatite particles produced according to the method. The nanocrystalline hydroxyapatite particles exhibit substantially superior cell transformation abilities as compared to known and commercially-available calcium phosphate kits. The nanocrystalline hydroxyapatite particles also find use in tissue engineering applications, for example bone and tooth engineering and repair applications.
REFERENCES:
patent: 5122418 (1992-06-01), Nakane et al.
patent: 5128169 (1992-07-01), Saita et al.
patent: 5258044 (1993-11-01), Lee
patent: 5292253 (1994-03-01), Levy
patent: 5306305 (1994-04-01), Lee
patent: 5441739 (1995-08-01), Kossovsky et al.
patent: 5460830 (1995-10-01), Kossovsky et al.
patent: 5460831 (1995-10-01), Kossovsky et al.
patent: 5462750 (1995-10-01), Kossovsky et al.
patent: 5462751 (1995-10-01), Kossovsky et al.
patent: 5464634 (1995-11-01), Kossovsky et al.
patent: 5543019 (1996-08-01), Lee et al.
patent: 5639505 (1997-06-01), Kossovsky et al.
patent: 5650176 (1997-07-01), Lee et al.
patent: 5676976 (1997-10-01), Lee et al.
patent: 5683461 (1997-11-01), Lee et al.
patent: 5763416 (1998-06-01), Bonadio et al.
patent: 5776193 (1998-07-01), Kwan et al.
patent: 5783217 (1998-07-01), Lee et al.
patent: 5843289 (1998-12-01), Lee et al.
patent: 5858318 (1999-01-01), Luo
patent: 5919426 (1999-07-01), Nakamoto et al.
patent: 6013591 (2000-01-01), Ying et al.
patent: 6027742 (2000-02-01), Lee et al.
patent: 6033582 (2000-03-01), Lee et al.
patent: 6117456 (2000-09-01), Lee et al.
patent: 6132463 (2000-10-01), Lee et al.
patent: 6171610 (2001-01-01), Vacanti et al.
patent: 6177273 (2001-01-01), Bennett et al.
patent: 6214368 (2001-04-01), Lee et al.
patent: 6309635 (2001-10-01), Ingber et al.
patent: 6348069 (2002-02-01), Vacanti et al.
patent: 6562069 (2003-05-01), Cai et al.
patent: 2002/0173478 (2002-11-01), Gewirtz
patent: WO 01/91848 (2001-12-01), None
patent: WO 02/02182 (2002-01-01), None
Watson, James D., Gilman, Michael, Witkowski, Jan, and Zoller, Mark, “Transferring Genes Into Mammalian Cells,”Recombinant DNA, 2nd ed., pp. 213-234, W. H. Freeman and Company, New York (1992).
Bonadio, Jeffrey, Smiley, Elizabeth, Patil, Pravin and Goldstein, Steven, “Localized, direct plasmid gene delivery in vivo; prolonged therapy results in reproducible tissue regeneration,”Nature Medicine, vol. 5, No. 7, pp. 753-759, (1999).
Xia, Haibin, Mao, Qinwen, Paulson, Henry L. and Davidson, Beverly L., “siRNA-mediated gene silencing in vitro and in vivo,”Nature Biotechnology, vol. 20, pp. 1006-1010, (2002).
Amrani, David L., Diorio, James P. and Delmotte, Yves, “Wound Healing: Role of Commercial Fibrin Sealants,”Annals New York Academy of Sciences, pp. 566-579.
Hollinger, Jeffrey O., Brekke, John, Gruskin, Elliott and Lee, Dosuk, “Role of Bone Substitutes,”Clinical Orthopaedics and Related Research, No. 324, pp. 55-65 (1996)/.
Nakashima, M., The Effects of Growth Factors on DNA Synthesis, Proteoglycan Synthesis and Alkaline Phosphatase Activity in Bovine Dental Pulp Cells,Archs oral Biol., vol. 37, No. 3, pp. 231-236 (1992).
Lasa, Carlos Jr., Hollinger, Jeffrey, Drohan, William and MacPhee, Martin, “Delivery of Demineralized Bone Powder by Fibrin Sealant,”Plastic and Reconstructive Surgery, vol. 96, No. 6, pp. 1409-1417 (1995).
Bolander, Mark E., Regulation of Fracture Repair by Growth Factors (43410A),Proceedings of the Society for Experimental Biology and Medicine, pp. 165-170, (1992).
Bègue-Kirin, Catherine, Smith, Anthony J., Ruch, Jean Victor et al., “Effects of dentin proteins, transforming growth factor β1 (TGFβ1) and bone morphogenetic protein 2 (CMP2) on the differentiation of odontoblast in vitro,”Int. J. Dev. Biol., 36: 491-503 (1992).
Imai, M. and Hayashi, Y., “Ultrastructure of wound healing following direct pulp capping with calcium-β-glycerophosphate (Ca-BGP),”J. Oral Pathol Med: 22; 411-417 (1993).
Abstract: Ren, Wen Hong, Yang, Lian Jia and Dong, Shao Zhong, “Induction of Reparative Dentin Formation in Dogs with Combined Recombinant Human Bone Morphogenetic Protein 2 and Fibrin Sealant,”Chinese Journal of Dental Research, vol. 2:3:21-24 (1999).
Carr, M.E. Jr. and Alving, B.M., “Effect of fibrin structure on plasmin-mediated dissolution of plasma clots,”Blood Coagulation and Fibrinolysis, vol. 6, pp. 567-573 (1995).
Hu, Y., Hollinger, J.O. and Marra, K.G., “Controlled Release from Coated Polymer Microparticles Embedded in Tissue-engineered Scaffolds,”Journal of Drug Targeting, vol. 9, pp. 431-438, (2001).
Hollinger, J., Mayer, M., Buck, D., Zegzula, H., et al., “Poly (α-hydroxy acid) carrier for delivering recombinant human bone morphogenetic protein-2 for bone regeneration,”Journal of Controlled Release, 39, pp. 287-304 (1996).
Abe, Nobuhiro, Lee, Yu-Po, Sato, Makoto, Zhang, Xuguang, et al., “Enhancement of bone repair with a helper-dependent adenoviral transfer of bone morphogenetic protein-2,”Biochemical and Biophysical Research Communications, vol. 297, pp. 523-527 (2002).
Davis, Sean E., Doss, David J., Humphrey, Jay D. and Wright, T. Neil, “Effects of Heat-Induced Damage on the Radial Component of Thermal Diffusivity of Bovine Aorta,”Journal of Biomechanical Engineering, vol. 122, pp. 283-285 (2000).
Oldham, J.B., Lu, L., Zhu, X. and Porter, B.D. et al., “Biological Activity of rhBMP-2 Released from PLGA Microspheres,”Journal of Biomechanical Engineering, vol. 122, pp. 289-292 (2000).
Porter, B.D., Oldham, J.B., He, S.-L. and Zobitz, M.E. et al., “Mechanical Properties of a Biodegradable Bone Regeneration Scaffold,”Journal of Biomechanical Engineering, vol. 122, pp. 286-288 (2000).
Ren, Wen Hong, Yang, Lian Jia and Dong, Shao Zhong, “Induction of Reparative Dentin Formation in Dogs with Combined Recombinant Human Bone Morphogenetic Protein 2 and Fibrin Sealant,”The Chinese Journal of Dental Research, vol. 2, No. 3/4, pp. 21-24 (1999).
Ikoma, Toshiyuki, Yamazaki, Atushi, Nakamura, Satoshi and Akao, Masaru, “Preparation and Structure Refinement of Monoclinic Hydroxyapatite,”Journal of Solid State Chemistry, vol. 144, 272-276 (1999).
Nowotny, R., Chalupka, A., Nowotny, Ch. and Bosch, P., “Preparation of fibrin clot samples for tensile stress-strain experiments,”Biomaterials, vol. 2, pp. 55-56 (1981).
Wigler, Michael, Pellicer, Angel, Silverstein, Saul and Axel, Richard, “Biochemical Transfer of Single-Copy Eucaryotic Genes Using Total Cellular DNA as Donor,”Cell., vol. 14, pp. 725-731 (1978).
Graham, F.L. and Van Der Eb, A.J., “Transformation of Rat Cells by DNA of Human Adenovirus,”Virology, vol. 54, pp. 536-639 (1973).
Toriyama, Motohiro, Kawamoto, Yukari, Suzuki, Takahiro et al., “Synthesis of Hydroxyapatite by an Oxidative Decomposition Method of Calcium Chelate,”Journal of the Ceramic Society of Japan. Int. Edition, vol. 100, pp. 939-943 (1992).
Zawa, T.Kana, “Hydroxyapatite,” in Inorganic Phosphate Materials,Materials Science Monographs, vol. 52, pp. 15-54 (1989).
Doremus, R.H., “Review Bioceramics,”Journal of Materials Science, vol. 27, pp. 285-297 (1992).
Hu, C.-C., Zhang, Chuhua, Qian, Qiubing and Tatum, Nanni B., “Reparative Dentin Formation in Rat Molars after Direct Pulp Capping with Growth Factors,”Journal of Endodontics, vol. 24, No. 11, pp. 744-751 (1998).
Spitzer, Ron-Sascha, Perka, Carsten, Lindenhayn, Klaus and Zippel, Hartmut, “Matrix engineering for osteogenic differentiation of rabbit periosteal cells using α-tricalcium phosphate particles in a three-dimensional fibrin culture,”J. Biomed. Mater. Res., pp. 690-696, (2002).
Nakashima, M., “The Induction of Reparative Dentine in the Amputated Dental Pulp of the Dog by Bone Morphogenetic Protein,”Arc
Campbell Phil
Choi Daiwon
Hollinger Jeffrey
Kumta Prashant N.
Sfeir Charles
Carnegie Mellon University
Kirkpatrick & Lockhart Preston Gates & Ellis LLP
Schnizer Richard
LandOfFree
Method of manufacturing hydroxyapatite and uses therefor in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of manufacturing hydroxyapatite and uses therefor in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of manufacturing hydroxyapatite and uses therefor in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3755985